Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin
Status:
Withdrawn
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as gemcitabine, docetaxel, and capecitabine, work
in different ways to stop the growth of tumor cells, either by killing the cells or by
stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill
more tumor cells.
PURPOSE: This phase II trial is studying how well giving gemcitabine together with docetaxel
and capecitabine works in treating patients with cancer of unknown primary origin.
Phase:
Phase 2
Details
Lead Sponsor:
University of Medicine and Dentistry of New Jersey